APA (7th ed.) Citation

P, T., T, V., I, B., Z, B., K, G., I, S., . . . M, A. (2018). Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis. Hematological oncology, 36(4), 645. https://doi.org/10.1002/hon.2521

Chicago Style (17th ed.) Citation

P, Tsirigotis, et al. "Positive Impact of Brentuximab Vedotin on Overall Survival of Patients with Classical Hodgkin Lymphoma Who Relapse or Progress After Autologous Stem Cell Transplantation: A Nationwide Analysis." Hematological Oncology 36, no. 4 (2018): 645. https://doi.org/10.1002/hon.2521.

MLA (9th ed.) Citation

P, Tsirigotis, et al. "Positive Impact of Brentuximab Vedotin on Overall Survival of Patients with Classical Hodgkin Lymphoma Who Relapse or Progress After Autologous Stem Cell Transplantation: A Nationwide Analysis." Hematological Oncology, vol. 36, no. 4, 2018, p. 645, https://doi.org/10.1002/hon.2521.